相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity
Naomi S. Rajapaksa et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors: an updated patent review (2016-2018)
William T. McElroy
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes
Vladimir Ramirez-Carrozzi et al.
JOURNAL OF IMMUNOLOGY (2019)
Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors
Marian C. Bryan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
New therapies for systemic lupus erythematosus - past imperfect, future tense
Grainne Murphy et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development
James J. y Crawford et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances
Marian C. Bryan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
CRISPR off-target analysis in genetically engineered rats and mice
Keith R. Anderson et al.
NATURE METHODS (2018)
Toll-like receptors in lupus nephritis
Satish Kumar Devarapu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2018)
Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity
Shailesh Dudhgaonkar et al.
JOURNAL OF IMMUNOLOGY (2017)
Enhanced Bruton's Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease
Odilia B. J. Corneth et al.
ARTHRITIS & RHEUMATOLOGY (2017)
BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils
D. Smiljkovic et al.
ALLERGY (2017)
Deficiency in IRAK4 activity attenuates manifestations of murine Lupus
Michael Murphy et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNa-driven lupus nephritis
Arna Katewa et al.
JCI INSIGHT (2017)
Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology
Karin Pelka et al.
IMMUNOLOGICAL REVIEWS (2016)
Btk inhibition treats TLR7/IFN driven murine lupus
Andrew T. Bender et al.
CLINICAL IMMUNOLOGY (2016)
Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
Raphael Bueno et al.
NATURE GENETICS (2016)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Systemic lupus erythematosus
Arvind Kaul et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Toll-like receptors: potential targets for lupus treatment
Yan-wei Wu et al.
ACTA PHARMACOLOGICA SINICA (2015)
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy
Priscilla N. Kelly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
B Cell-Specific MHC Class II Deletion Reveals Multiple Nonredundant Roles for B Cell Antigen Presentation in Murine Lupus
Josephine R. Giles et al.
JOURNAL OF IMMUNOLOGY (2015)
The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression
T. Hung et al.
SCIENCE (2015)
Dual B Cell Immunotherapy Is Superior to Individual Anti-CD20 Depletion or BAFF Blockade in Murine Models of Spontaneous or Accelerated Lupus
WeiYu Lin et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Belimumab in systemic lupus erythematosus
Andreia Vilas-Boas et al.
RMD OPEN (2015)
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE
William P. Kennedy et al.
LUPUS SCIENCE & MEDICINE (2015)
Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation
Vassilios Lougaris et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome
Eric G. Meissner et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Type I Interferon in the Pathogenesis of Lupus
Mary K. Crow
JOURNAL OF IMMUNOLOGY (2014)
A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4
Laia Alsina et al.
NATURE IMMUNOLOGY (2014)
Bruton's Tyrosine Kinase and Protein Kinase C μ Are Required for TLR7/9-Induced IKKα and IRF-1 Activation and Interferon-β Production in Conventional Dendritic Cells
Yan-Feng Li et al.
PLOS ONE (2014)
Epicutaneous Application of Toll-like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild-Type Mice
Maki Yokogawa et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy In Vivo
Marc Lamphier et al.
MOLECULAR PHARMACOLOGY (2014)
Suppression of Glomerulonephritis in Lupus-Prone NZB x NZW Mice by RN486, a Selective Inhibitor of Bruton's Tyrosine Kinase
Paola Mina-Osorio et al.
ARTHRITIS AND RHEUMATISM (2013)
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis
Yonglian Sun et al.
AUTOIMMUNITY (2013)
TLRs and interferons: a central paradigm in autoimmunity
Dwight H. Kono et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis
Andrew L. Rankin et al.
JOURNAL OF IMMUNOLOGY (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
IgM+IgD+CD27+B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAP- but not UNC-93B-deficient patients
Sandra Weller et al.
BLOOD (2012)
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Julie A. Di Paolo et al.
NATURE CHEMICAL BIOLOGY (2011)
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling
Su-Chang Lin et al.
NATURE (2010)
Induction of autoimmunity by pristane and other naturally occurring hydrocarbons
Westley H. Reeves et al.
TRENDS IN IMMUNOLOGY (2009)
Requirement of toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis
Emina Savarese et al.
ARTHRITIS AND RHEUMATISM (2008)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses
Elizabeth Lye et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Sites and stages of autoreactive B cell activation and regulation
Mark J. Shlomchik
IMMUNITY (2008)
Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice
Maroof Hasan et al.
IMMUNOLOGY (2008)
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Michel Gilliet et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor- mediated immune responses but not in TCR signaling
Tatsukata Kawagoe et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity
Tae Whan Kim et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Bruton's tyrosine kinase is required for TLR2 and TLR4-Induced TNF, but not IL-6, production
Nicole J. Horwood et al.
JOURNAL OF IMMUNOLOGY (2006)
Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
J Vollmer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement
CM Lau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9
TK Means et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes
MW Boulé et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Induction of interferon-a production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late anoptotic cells and lupus IgG
T Lövgren et al.
ARTHRITIS AND RHEUMATISM (2004)
FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG
U Båve et al.
JOURNAL OF IMMUNOLOGY (2003)
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
G Jego et al.
IMMUNITY (2003)
Bruton's tyrosine kinase is a toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by toll-like receptor 4
CA Jefferies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells
NL Bernasconi et al.
BLOOD (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Maintenance of serological memory by polyclonal activation of human memory B cells
NL Bernasconi et al.
SCIENCE (2002)
分享论文
